The exploration of the genetic and epigenetic architecture of age-related cognitive decline and dementia is accelerating rapidly. Genome-wide association scan approaches that have proven very effective in other human disorders have now begun to yield dividends in aging-related central nervous system diseases. The challenge is now turning to understanding the functional consequences within the brain of variation in DNA sequence associated with disease. In this proposal, we explore the transcriptome of several discrete brain regions implicated in cognitive decline to discover which RNA species, isoforms, and broader RNA profiles are correlated with the functional impairment of the central nervous system that occurs with advancing age. These transcriptome profiles are collected from postmortem tissue collected from subjects of two cohort studies that have accumulated longitudinal cognitive data on their subjects: the Religious Order Study (Exploratory Cohort) and the Memory and Aging Project (Confirmatory Cohort). In total, over 1200 individuals from the two cohorts will be included in the study. Our approach using next generation sequencing to create these transcriptomes will allow an unparalleled perspective on the complexity of transcriptional regulation of the brain, which is a tissue with one of the most diverse content of alternatively spliced transcripts, many of which may not have been catalogued previously. Further, the large number of subjects profiled in the same discrete brain regions will allow a powerful assessment of the extent of interindividual variation in the proportion of RNA isoforms. By relating these transcriptome profiles to the cognitive trajectory of the subjects prior to death, we will be able to assess which genes, isoforms and pathways may be involved in cognitive decline. Finally, the availability of both genome-wide genotype data and DNA methylation data on the same tissue samples profiled for RNA expression give us a unique opportunity to explore the causal network linking genetic variation, chromatin conformation, RNA expression, cognitive decline measures, and clinical dementia. Thus, we may gain insight not only into the transcriptome diversity of the older human brain but also into the manner in which genetic and epigenetic variation associated with clinically impaired cognition exert a functional consequence on the human brain.

Public Health Relevance

The goal of this project is to understand which brain molecules are involved in the decline of memory and thinking in older individuals as they age. Identifying these molecules and understanding how it relates with genetic risk for diseases that affect memory and the ability to think will help investigators understand the natural decline in brain function that occurs with aging. This new knowledge could then be developed into a test with which to (1) predict those individuals at risk for earlier or more severe brain function decline and (2) create a new base of knowledge from which, ultimately, to develop new drugs to prevent brain function decline.

Agency
National Institute of Health (NIH)
Type
Research Project (R01)
Project #
5R01AG036836-04
Application #
8726262
Study Section
Neurological, Aging and Musculoskeletal Epidemiology Study Section (NAME)
Program Officer
Wagster, Molly V
Project Start
Project End
Budget Start
Budget End
Support Year
4
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02115
Hohman, Timothy J; Bush, William S; Jiang, Lan et al. (2016) Discovery of gene-gene interactions across multiple independent data sets of late onset Alzheimer disease from the Alzheimer Disease Genetics Consortium. Neurobiol Aging 38:141-50
Buchman, Aron S; Yu, Lei; Boyle, Patricia A et al. (2016) Higher brain BDNF gene expression is associated with slower cognitive decline in older adults. Neurology 86:735-41
Cade, Brian E; Gottlieb, Daniel J; Lauderdale, Diane S et al. (2016) Common variants in DRD2 are associated with sleep duration: the CARe consortium. Hum Mol Genet 25:167-79
Fromer, Menachem; Roussos, Panos; Sieberts, Solveig K et al. (2016) Gene expression elucidates functional impact of polygenic risk for schizophrenia. Nat Neurosci 19:1442-1453
Gaiteri, Chris; Mostafavi, Sara; Honey, Christopher J et al. (2016) Genetic variants in Alzheimer disease - molecular and brain network approaches. Nat Rev Neurol 12:413-27
Valenca, Guilherme T; Srivastava, Gyan P; Oliveira-Filho, Jamary et al. (2016) The Role of MAPT Haplotype H2 and Isoform 1N/4R in Parkinsonism of Older Adults. PLoS One 11:e0157452
Yu, Lei; De Jager, Philip L; Yang, Jingyun et al. (2015) The TMEM106B locus and TDP-43 pathology in older persons without FTLD. Neurology 84:927-34
Bennett, David A; Yu, Lei; Yang, Jingyun et al. (2015) Epigenomics of Alzheimer's disease. Transl Res 165:200-20
Replogle, Joseph M; Chan, Gail; White, Charles C et al. (2015) A TREM1 variant alters the accumulation of Alzheimer-related amyloid pathology. Ann Neurol 77:469-77
Yu, Lei; Chibnik, Lori B; Srivastava, Gyan P et al. (2015) Association of Brain DNA methylation in SORL1, ABCA7, HLA-DRB5, SLC24A4, and BIN1 with pathological diagnosis of Alzheimer disease. JAMA Neurol 72:15-24

Showing the most recent 10 out of 19 publications